- Home
- OZK vs AKRO Comparison
OZK vs AKRO Comparison
Compare OZK & AKRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OZK
- AKRO
- Stock Information
- Founded
- OZK 1903
- AKRO 2017
- Country
- OZK United States
- AKRO United States
- Employees
- OZK N/A
- AKRO N/A
- Industry
- OZK Major Banks
- AKRO Biotechnology: Pharmaceutical Preparations
- Sector
- OZK Finance
- AKRO Health Care
- Exchange
- OZK Nasdaq
- AKRO Nasdaq
- Market Cap
- OZK 4.4B
- AKRO 3.9B
- IPO Year
- OZK 1997
- AKRO 2019
- Fundamental
- Price
- OZK $44.16
- AKRO $50.86
- Analyst Decision
- OZK Hold
- AKRO Strong Buy
- Analyst Count
- OZK 9
- AKRO 8
- Target Price
- OZK $49.13
- AKRO $82.50
- AVG Volume (30 Days)
- OZK 788.1K
- AKRO 1.9M
- Earning Date
- OZK 07-16-2025
- AKRO 05-12-2025
- Dividend Yield
- OZK 3.75%
- AKRO N/A
- EPS Growth
- OZK 2.15
- AKRO N/A
- EPS
- OZK 6.10
- AKRO N/A
- Revenue
- OZK $1,488,963,000.00
- AKRO N/A
- Revenue This Year
- OZK $15.44
- AKRO N/A
- Revenue Next Year
- OZK $5.32
- AKRO N/A
- P/E Ratio
- OZK $7.27
- AKRO N/A
- Revenue Growth
- OZK 6.47
- AKRO N/A
- 52 Week Low
- OZK $35.71
- AKRO $17.86
- 52 Week High
- OZK $53.64
- AKRO $58.40
- Technical
- Relative Strength Index (RSI)
- OZK 44.41
- AKRO 64.52
- Support Level
- OZK $43.72
- AKRO $44.94
- Resistance Level
- OZK $45.59
- AKRO $51.66
- Average True Range (ATR)
- OZK 0.85
- AKRO 3.29
- MACD
- OZK -0.33
- AKRO 0.73
- Stochastic Oscillator
- OZK 1.85
- AKRO 91.10
About OZK Bank OZK
Bank OZK is a bank holding company that owns and operates a community bank, Bank of the Ozarks. The bank operates offices in Arkansas, Georgia, Florida, North Carolina, Texas, California, New York and Mississippi. It provides a range of banking services which include deposit services such as checking, savings, money market, time deposit, and individual retirement accounts to loan services like real estate, consumer, commercial, and industrial loans. Apart from providing traditional banking products and services it also provides treasury management, trust and wealth management, financial planning, online banking, and other related services.
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.